Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities.

Zhou, Peng; Chen, Zhuo; Zhao, Ning; Liu, Dan; Guo, Zi-Yuan; Tan, Lu; Hu, Juan; Wang, Qun; Wang, Jian-Zhi; Zhu, Ling-Qiang

Zhou, Peng; Chen, Zhuo; Zhao, Ning; Liu, Dan; Guo, Zi-Yuan; Tan, Lu; Hu, Juan; Wang, Qun; Wang, Jian-Zhi; Zhu, Ling-Qiang.

Affiliation

Zhou P; Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.

Rejuvenation Res ; 14(6): 669-79, 2011 Dec.

Article in En | MEDLINE | ID: mdl-21978079

Subject(s)

Acetylcarnitine/pharmacology; Alzheimer Disease/drug therapy; Alzheimer Disease/metabolism; Homocysteine/metabolism; Amyloid beta-Protein Precursor/metabolism; Animals; Behavior, Animal; Brain/metabolism; Disease Models, Animal; Hippocampus/metabolism; Male; Maze Learning; Phosphorylation; Rats; Rats, Sprague-Dawley; Silver Staining; tau Proteins/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Acetylcarnitine / Alzheimer Disease / Homocysteine Language: En Journal: Rejuvenation Res Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Acetylcarnitine / Alzheimer Disease / Homocysteine Language: En Journal: Rejuvenation Res Year: 2011 Type: Article